MX2010004836A - Composicion de quitosan. - Google Patents
Composicion de quitosan.Info
- Publication number
- MX2010004836A MX2010004836A MX2010004836A MX2010004836A MX2010004836A MX 2010004836 A MX2010004836 A MX 2010004836A MX 2010004836 A MX2010004836 A MX 2010004836A MX 2010004836 A MX2010004836 A MX 2010004836A MX 2010004836 A MX2010004836 A MX 2010004836A
- Authority
- MX
- Mexico
- Prior art keywords
- chitosan
- cross
- linking agent
- chitosan composition
- composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6903—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being semi-solid, e.g. an ointment, a gel, a hydrogel or a solidifying gel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
- A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1213—Semi-solid forms, gels, hydrogels, ointments, fats and waxes that are solid at room temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Physics & Mathematics (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Cosmetics (AREA)
Abstract
La presente invención se refiere a una composición de quitosan reticulable que comprende quitosan que tiene un grado de desacetilacicón entre 30% y 75%, en donde el quitosan es desacetilado en forma aleatoria, y un agente de reticulación, en donde la proporción molar del agente de reticulación al quitosan es de 0.2: 1 o menos con base en el número de grupos funcionales en el agente de reticulación y el número de grupos amino accesibles en el quitosan. La presente invención también proporciona un hidrogel de quitosan formado del mismo y usos del mismo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98362307P | 2007-10-30 | 2007-10-30 | |
PCT/EP2008/064737 WO2009056602A1 (en) | 2007-10-30 | 2008-10-30 | Chitosan composition |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010004836A true MX2010004836A (es) | 2010-10-20 |
Family
ID=40427543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010004836A MX2010004836A (es) | 2007-10-30 | 2008-10-30 | Composicion de quitosan. |
Country Status (13)
Country | Link |
---|---|
US (1) | US8703924B2 (es) |
EP (1) | EP2209813A1 (es) |
JP (1) | JP5725862B2 (es) |
KR (1) | KR101545506B1 (es) |
CN (1) | CN101903408B (es) |
AU (1) | AU2008320877B2 (es) |
BR (1) | BRPI0817895A2 (es) |
CA (1) | CA2704162C (es) |
MX (1) | MX2010004836A (es) |
NZ (1) | NZ584996A (es) |
RU (1) | RU2482133C2 (es) |
WO (1) | WO2009056602A1 (es) |
ZA (1) | ZA201003041B (es) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2526183C1 (ru) * | 2013-02-28 | 2014-08-20 | Федеральное государственное унитарное предприятие Научно-производственный центр "Фармзащита" Федерального медико-биологического агентства (ФГУП НПЦ "Фармзащита" ФМБА России) | Гемостатическая противоожоговая ранозаживляющая композиция |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8398638B2 (en) * | 2004-08-30 | 2013-03-19 | Spineovations, Inc. | Method of treating spinal internal disk derangement |
US20100004700A1 (en) * | 2008-03-05 | 2010-01-07 | Neville Alleyne | Method of treating tissue with a suspenson of tricalcium hydroxyapatite microspheres |
US8469961B2 (en) * | 2008-03-05 | 2013-06-25 | Neville Alleyne | Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints |
US9234100B2 (en) | 2009-02-20 | 2016-01-12 | Uniboard Canada Inc. | Chitosan-based adhesives and uses thereof |
EP2408435B1 (en) * | 2009-03-16 | 2019-04-24 | University Of Memphis Research Foundation | Compositions and methods for delivering an agent to a wound |
AU2010303552B2 (en) * | 2009-10-06 | 2013-11-14 | Regents Of The University Of Minnesota | Bioresorbable embolization microspheres |
US9309435B2 (en) | 2010-03-29 | 2016-04-12 | The Clorox Company | Precursor polyelectrolyte complexes compositions comprising oxidants |
US20110236582A1 (en) | 2010-03-29 | 2011-09-29 | Scheuing David R | Polyelectrolyte Complexes |
US9474269B2 (en) | 2010-03-29 | 2016-10-25 | The Clorox Company | Aqueous compositions comprising associative polyelectrolyte complexes (PEC) |
PL2566454T3 (pl) * | 2010-05-04 | 2014-05-30 | Viscogel Ab | Kompozycja chitozanu |
FR2975706B1 (fr) * | 2011-05-26 | 2017-07-21 | Ifremer (Institut Francais De Rech Pour L'exploitation De La Mer) | Extraction de chitines en une seule etape par hydrolyse enzymatique en milieu acide |
GB201116050D0 (en) | 2011-09-16 | 2011-11-02 | Ntnu Technology Transfer As | Ionic gel |
US9867909B2 (en) | 2011-09-30 | 2018-01-16 | Sofradim Production | Multilayer implants for delivery of therapeutic agents |
US20130096082A1 (en) * | 2011-10-11 | 2013-04-18 | Baxter Healthcare S.A. | Hemostatic compositions |
US8889655B2 (en) | 2012-07-20 | 2014-11-18 | Aegis Women's Health Technologies | Compositions and methods for preventing infectious diseases in females |
MY190866A (en) | 2012-10-29 | 2022-05-13 | Univ Arkansas | Novel mucosal adjuvants and delivery systems |
EP3003026B1 (en) | 2013-03-14 | 2019-07-17 | Tricol Biomedical, Inc. | Biocompatible and bioabsorbable derivatized chitosan compositions |
US9662400B2 (en) | 2013-03-14 | 2017-05-30 | The University Of Memphis Research Foundation | Methods for producing a biodegradable chitosan composition and uses thereof |
GB2514597A (en) * | 2013-05-30 | 2014-12-03 | Medtrade Products Ltd | Degradable haemostat composition |
GB2514592A (en) * | 2013-05-30 | 2014-12-03 | Medtrade Products Ltd | Degradable haemostat composition |
EP3006047B1 (en) * | 2013-06-06 | 2019-08-07 | Toppan Printing Co., Ltd. | Needle body |
GB201316082D0 (en) | 2013-09-09 | 2013-10-23 | Viscogel Ab | Chitosan composition |
US9192692B2 (en) | 2013-10-24 | 2015-11-24 | Medtronic Xomed, Inc. | Chitosan stenting paste |
US9192574B2 (en) | 2013-10-24 | 2015-11-24 | Medtronic Xomed, Inc. | Chitosan paste wound dressing |
EP2886644A1 (en) | 2013-12-20 | 2015-06-24 | Kallistem | Process for implementing in vitro spermatogenesis and associated device |
US10172975B2 (en) | 2013-12-24 | 2019-01-08 | Greenever | Gel-forming agent comprising sulfa agent and chitosan agent and having powdered dosage form |
FR3016882A1 (fr) | 2014-01-30 | 2015-07-31 | Sofradim Production | Procede de preparation de chitosane a haut degre d’acetylation |
RU2583886C2 (ru) * | 2014-02-28 | 2016-05-10 | Пётр Евгеньевич Игнатов | Мультипотентная вакцина для профилактики и лечения преимущественно инвазионных и инфекционных болезней, способ применения |
AR099900A1 (es) | 2014-04-01 | 2016-08-24 | Merz Pharma Gmbh & Co Kgaa | Rellenos para tejidos blandos con polisacáridos con persistencia mejorada, kit, procedimiento, uso |
US8975220B1 (en) | 2014-08-11 | 2015-03-10 | The Clorox Company | Hypohalite compositions comprising a cationic polymer |
ES2693579T3 (es) | 2015-01-16 | 2018-12-12 | Spineovations, Inc. | Método de tratamiento del disco intervertebral |
US10126298B2 (en) | 2015-05-04 | 2018-11-13 | Arman Nabatian | Hydrogels containing embedded substrates for targeted binding of molecules |
FR3038318B1 (fr) * | 2015-07-02 | 2017-08-04 | Univ De Lille 1 Sciences Et Technologies | Procede de fabrication d'hydrogel a base de chitosan et de polyelectrolytes charges negativement et materiau poreux alveolaire issu dudit hydrogel |
US10182979B2 (en) | 2016-03-22 | 2019-01-22 | Regents Of The University Of Minnesota | Biodegradable microspheres |
MX2018013122A (es) * | 2016-04-26 | 2019-03-28 | Viaqua Therapeutics Ltd | Composiciones y procedimientos para tratar infecciones viricas en gambas. |
CN105754566B (zh) * | 2016-05-06 | 2018-09-21 | 西南石油大学 | 一种多糖聚合物堵水凝胶 |
IT201600070911A1 (it) | 2016-07-07 | 2018-01-07 | Univ Degli Studi Di Torino | Composizione comprendente chitosano per l'uso nella prevenzione e/o nel trattamento di incontinenza e/o impotenza in un soggetto sottoposto a prostatectomia |
US10836872B2 (en) | 2016-08-11 | 2020-11-17 | The Catholic University Of Korea Industry-Academy Cooperation | Visible light-curable water-soluble chitosan derivative, chitosan hydrogel, and preparation method therefor |
CN107376032A (zh) * | 2017-08-16 | 2017-11-24 | 复旦大学 | 一种膀胱输尿管反流注射治疗用填充剂及其制备方法 |
RU2707973C1 (ru) * | 2019-02-15 | 2019-12-03 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский национальный исследовательский государственный университет имени Н.Г. Чернышевского" | Гидрогелевый материал на основе соли хитозансодержащего вещества и способ его получения |
EP3733755A1 (en) | 2019-04-30 | 2020-11-04 | Universita Degli Studi di Trieste | Homogeneous hydrogels from chitosan oligosaccharide derivatives and applications thereof |
CN111187607B (zh) * | 2019-07-15 | 2022-07-01 | 浙江工业大学 | 一种温度响应型水凝胶暂堵转向压裂液及其制备方法、应用 |
KR102503193B1 (ko) * | 2019-11-04 | 2023-02-23 | 주식회사 엔도비전 | 버섯 또는 진균 유래 키토산, 또는 그 유도체를 이용한 하이드로겔 및 그 제조방법 |
EP3944864A1 (en) * | 2020-07-31 | 2022-02-02 | Theranosticentre S.r.l. | Polymers and hydrogels for application with neutron intra-operative radiation therapy |
CN112300437A (zh) * | 2020-11-17 | 2021-02-02 | 齐鲁工业大学 | 一种橘皮果胶基多孔吸水可食用凝胶的制备方法 |
CA3141366A1 (en) * | 2020-12-09 | 2022-06-09 | Mcmaster University | Polymer system for ophthalmic drug delivery |
CN113046164B (zh) * | 2021-03-30 | 2022-05-17 | 扬州工业职业技术学院 | 一种环境响应型水基润滑剂及其制备方法 |
CN114437152B (zh) * | 2021-12-31 | 2024-03-26 | 蚌埠市华东生物科技有限公司 | 一种甜菊糖苷水提液的脱色除杂方法 |
CN115491105A (zh) * | 2022-09-30 | 2022-12-20 | 武汉材料保护研究所有限公司 | 壳聚糖-没食子酸协同改性水性带锈涂料及其制备方法 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6176504A (ja) * | 1984-09-21 | 1986-04-19 | Fuji Boseki Kk | 粒状多孔質キトサンの製造法 |
JPS6397633A (ja) * | 1986-10-13 | 1988-04-28 | Fuji Boseki Kk | 新規なキトサン粒状物 |
US5690954A (en) * | 1987-05-22 | 1997-11-25 | Danbiosyst Uk Limited | Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material |
JP2514824B2 (ja) * | 1987-10-15 | 1996-07-10 | 日本ピー・エム・シー株式会社 | 水溶性熱硬化性キトサンの製造法 |
JPH02180903A (ja) * | 1988-12-29 | 1990-07-13 | Nippon Oil & Fats Co Ltd | 架橋キトサン |
US5708152A (en) * | 1992-03-27 | 1998-01-13 | Ciba Specialty Chemicals Corporation | N-substituted chitosan derivatives in a process for their preparation |
US5599916A (en) * | 1994-12-22 | 1997-02-04 | Kimberly-Clark Corporation | Chitosan salts having improved absorbent properties and process for the preparation thereof |
JP3030755B2 (ja) * | 1995-02-03 | 2000-04-10 | 富士紡績株式会社 | 酵素固定化用担体の製造方法 |
JPH09165404A (ja) * | 1995-12-15 | 1997-06-24 | Nippon Paper Ind Co Ltd | 表面n−チオカルバモイル化キトサン成形体およびその製造方法 |
DE19604706A1 (de) * | 1996-02-09 | 1997-08-14 | Merck Patent Gmbh | Vernetzungsprodukte von Aminogruppen-haltigen Biopolymeren |
ATE393171T1 (de) * | 1998-11-10 | 2008-05-15 | Netech Inc | Funktionelle chitosanderivate |
CN1128167C (zh) * | 2001-04-26 | 2003-11-19 | 南京大学 | 一种壳聚糖-聚丙烯酸复合物的纳米微球及其制法和用途 |
CA2467049C (en) * | 2001-11-15 | 2011-04-12 | Abdellatif Chenite | Composition and method to homogeneously modify or cross-link chitosan under neutral conditions |
JP4310967B2 (ja) * | 2002-03-26 | 2009-08-12 | 凸版印刷株式会社 | 多糖類複合体の製造方法 |
JP3924612B2 (ja) * | 2002-10-11 | 2007-06-06 | 独立行政法人農業生物資源研究所 | 絹タンパク質とキトサンとの複合体およびその製造方法 |
JP2004131622A (ja) * | 2002-10-11 | 2004-04-30 | Dainichiseika Color & Chem Mfg Co Ltd | キトサン水溶液、その製造方法および物品の被覆方法 |
GB0329907D0 (en) * | 2003-12-23 | 2004-01-28 | Innomed Ltd | Compositions |
CN1330386C (zh) * | 2005-12-07 | 2007-08-08 | 浙江大学 | 用于组织工程的可注射性壳聚糖水凝胶的制备方法 |
BRPI0520742A2 (pt) | 2005-12-23 | 2010-01-12 | Medidom Lab | composição de quitosana neutralizada termoestável que forma um hidrogel, produto liofilizado, e processos para produzir a mesma |
CN100496619C (zh) * | 2007-01-11 | 2009-06-10 | 南京零一新材料工程研究中心 | 可生物降解的壳聚糖多孔止血材料及其制备方法 |
-
2008
- 2008-10-30 EP EP08845345A patent/EP2209813A1/en not_active Withdrawn
- 2008-10-30 CA CA2704162A patent/CA2704162C/en not_active Expired - Fee Related
- 2008-10-30 JP JP2010531528A patent/JP5725862B2/ja not_active Expired - Fee Related
- 2008-10-30 AU AU2008320877A patent/AU2008320877B2/en not_active Ceased
- 2008-10-30 CN CN2008801218590A patent/CN101903408B/zh not_active Expired - Fee Related
- 2008-10-30 NZ NZ584996A patent/NZ584996A/en not_active IP Right Cessation
- 2008-10-30 BR BRPI0817895 patent/BRPI0817895A2/pt not_active IP Right Cessation
- 2008-10-30 US US12/740,942 patent/US8703924B2/en not_active Expired - Fee Related
- 2008-10-30 WO PCT/EP2008/064737 patent/WO2009056602A1/en active Application Filing
- 2008-10-30 RU RU2010117016/13A patent/RU2482133C2/ru not_active IP Right Cessation
- 2008-10-30 KR KR1020107011888A patent/KR101545506B1/ko not_active IP Right Cessation
- 2008-10-30 MX MX2010004836A patent/MX2010004836A/es active IP Right Grant
-
2010
- 2010-04-30 ZA ZA2010/03041A patent/ZA201003041B/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2526183C1 (ru) * | 2013-02-28 | 2014-08-20 | Федеральное государственное унитарное предприятие Научно-производственный центр "Фармзащита" Федерального медико-биологического агентства (ФГУП НПЦ "Фармзащита" ФМБА России) | Гемостатическая противоожоговая ранозаживляющая композиция |
Also Published As
Publication number | Publication date |
---|---|
US20100316715A1 (en) | 2010-12-16 |
CA2704162A1 (en) | 2009-05-07 |
CA2704162C (en) | 2016-04-12 |
KR20100083836A (ko) | 2010-07-22 |
US8703924B2 (en) | 2014-04-22 |
NZ584996A (en) | 2012-07-27 |
AU2008320877A1 (en) | 2009-05-07 |
CN101903408A (zh) | 2010-12-01 |
ZA201003041B (en) | 2011-07-27 |
CN101903408B (zh) | 2013-08-14 |
BRPI0817895A2 (pt) | 2015-03-31 |
RU2010117016A (ru) | 2011-12-10 |
JP5725862B2 (ja) | 2015-05-27 |
JP2011500955A (ja) | 2011-01-06 |
AU2008320877B2 (en) | 2013-03-14 |
RU2482133C2 (ru) | 2013-05-20 |
KR101545506B1 (ko) | 2015-08-19 |
EP2209813A1 (en) | 2010-07-28 |
WO2009056602A1 (en) | 2009-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010004836A (es) | Composicion de quitosan. | |
WO2007085552A3 (en) | Polymeric anti-microbial agents | |
WO2008015249A3 (en) | Cosmetic or pharmaceutical composition containing hyaluronic acid | |
MX2007004807A (es) | Composiciones para el cuidado del cabello. | |
WO2008131451A3 (en) | Pva-paa hydrogels | |
EP2772254A3 (en) | Novel Antibacterial Agents | |
MX2019008051A (es) | Composiciones polimericas reticulables in-situ y metodos de las mismas. | |
WO2007008978A3 (en) | Electrochromic devices utilizing very low band gap conjugated polymers: preparation and use | |
TW200738817A (en) | Blends of biopolymers with acrylic copolymers | |
WO2006125082A3 (en) | Hydrogels and hydrogel particles | |
EP2647701A3 (en) | Compositions and methods comprising variant microbial proteases | |
MX301592B (es) | Polimeros que contienen vinilamina modificada con aditivos en la fabricacion de papel. | |
WO2008043735A3 (de) | Zusammensetzungen aus teilweise silylterminierten polymeren | |
WO2006116458A3 (en) | Modified oligoribonucleotide analogs with enhances immunostimulatory activity | |
NZ603479A (en) | Chitosan composition | |
WO2008051318A3 (en) | Shape memory polymers | |
TW200613479A (en) | Coating formulation having improved rheological properties | |
BR0116773A (pt) | Composição na forma de uma dispersão aquosa | |
EP2395048A3 (en) | Polymers compositions including an antioxidant | |
MX2009003600A (es) | Composiciones que tienen un compartimiento indicador. | |
EP2061663A4 (en) | ELASTOMER COMPOSITION WITH GLASS MICROFIBERS | |
DE502005009570D1 (de) | Kosmetische formulierung enthaltend chitosan | |
AU2008250633A8 (en) | Medical devices comprising a Co-Polymer of a modified polyamide and a polyether | |
WO2008085578A3 (en) | Anti-microbial compositions and devices and methods of using the same | |
TW200700525A (en) | Adhesion-imparting agent and adhesion-imparting resin emulsion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |